Listen "빅파마가 직면한 세포유전자 치료제 시장의 현실 (Korean-language podcast)"
Episode Synopsis
빅파마들은 세포유전자 치료제를 출시하면서 이러한 치료의 비용과 복잡성이라는 현실적인 문제에 직면해 있습니다. 최근 개최된 메사 세포유전자 회의를 취재한 Scrip 기사를 요약한 내용입니다.
https://scrip.citeline.com/SC151041/Big-Pharma-Faces-Cell-And-Gene-Therapy-Market-Realities
Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
https://scrip.citeline.com/SC151041/Big-Pharma-Faces-Cell-And-Gene-Therapy-Market-Realities
Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
More episodes of the podcast Citeline Podcasts
Datamonitor Healthcare Podcast: ESMO 2025
12/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025
04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
31/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.